Trans Genic Inc. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 11,429 million. Net loss was JPY 409 million.
Basic loss per share from continuing operations was JPY 24.32.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
241 JPY | 0.00% | +3.43% | -7.31% |
Trans Genic Inc. reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was JPY 11,429 million. Net loss was JPY 409 million.
Basic loss per share from continuing operations was JPY 24.32.
1st Jan change | Capi. | |
---|---|---|
-7.31% | 25.64M | |
+15.44% | 51.69B | |
+37.43% | 39.73B | |
+14.21% | 10.11B | |
+15.53% | 8.7B | |
-21.57% | 7.31B | |
+11.21% | 6.38B | |
-2.90% | 5.78B | |
+13.80% | 5.38B | |
-51.24% | 3.52B |